'Lindsay is on track to deliver underlying EBITDA towards the lower end of the previously provided guidance range of $102 million - $108 million in FY24 up c.13% on the pcp. We expect any delay in recovery in the Rural and Hunters businesses to be offset by performance in the transport division, supported by a slowing in the inflationary outlook and the non-discretionary spend nature of the bulk of Lindsay’s logistics freight. The Board continues to monitor the impacts of events as circumstances are subject to sudden change.'
Net Debt $120.6m up 12.5%. Net Leverage Ratio down from 1.27x to 1.21x (4.9%).
Cash flow negative $18.6m primarily due to WB Hunter acquisition. Note 15 in the accounts tells me they have have not yet worked through all aspects of the acquisition, particulary intangibles/goodwill which represented 42% of total purchase consideration.
- Forums
- ASX - By Stock
- Ann: Half year FY24 Results Presentation
'Lindsay is on track to deliver underlying EBITDA towards the...
Featured News
Add LAU (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.5¢ |
Change
0.075(8.62%) |
Mkt cap ! $297.5M |
Open | High | Low | Value | Volume |
88.0¢ | 94.5¢ | 88.0¢ | $1.020M | 1.108M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 47051 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 161427 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47051 | 0.940 |
1 | 545 | 0.935 |
1 | 45000 | 0.930 |
2 | 6132 | 0.925 |
1 | 15000 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 161427 | 5 |
0.950 | 134592 | 4 |
0.955 | 2430 | 2 |
0.960 | 50736 | 5 |
0.965 | 526 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
LAU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online